Search - tctmd.com

Displaying 541 - 560 of 1417

Sort: Relevancy | Date

News Conference News ISET 2016

To Check or Not to Check? Carotid Screening Should be Limited to Highly Selected Patients, Say Experts

Michael O'Riordan

February 07, 2016

Presentation ISET 2016

Peripheral Applications of Bioabsorbable Stents

Presenter: Michael Dake

February 07, 2016

News Daily News

Un Centro Experimenta un Descenso en el Volumen y Reembolsos PCI Tras Implementar CUA

Michael O'Riordan

February 04, 2016

News Daily News

Center Experiences Declining PCI Volume, Reimbursement After Implementing AUC

Michael O'Riordan

February 04, 2016

News Daily News

AUC 实施后医疗中心 PCI 量和报销额都下降

Michael O'Riordan

February 04, 2016

News Daily News

血压低于 140 毫米汞柱时卒中减少，进一步支持指南采用更低阈值

Michael O'Riordan

February 02, 2016

News Daily News

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Michael O'Riordan

February 02, 2016

News Daily News

Menos ACV con Presiones Arteriales Menor que 140 mm Hg Animan a Rebajar los Umbrales

Michael O'Riordan

February 02, 2016

News Industry News

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

February 02, 2016

News Daily News

High Baseline Fitness Level Tied to Improved Survival After MI

Michael O'Riordan

February 01, 2016

News Daily News

Un Estudio Sugiere que las UCC Pueden Evitarse en Muchos Pacientes SCASEST

Todd Neale

January 28, 2016

News Daily News

Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años

Michael O'Riordan

January 28, 2016

News Daily News

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

Michael O'Riordan

January 28, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

研究表明，很多 NSTE-ACS 患者可以跳过 CCU 这一步

Todd Neale

January 28, 2016

News Daily News

Study Suggests CCU Can Be Skipped for Many NSTE-ACS Patients

Todd Neale

January 28, 2016

News Daily News

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Michael O'Riordan

January 26, 2016

News Daily News

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Michael O'Riordan

January 26, 2016

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

Advertisement

To Check or Not to Check? Carotid Screening Should be Limited to Highly Selected Patients, Say Experts

Peripheral Applications of Bioabsorbable Stents

Un Centro Experimenta un Descenso en el Volumen y Reembolsos PCI Tras Implementar CUA

Center Experiences Declining PCI Volume, Reimbursement After Implementing AUC

AUC 实施后医疗中心 PCI 量和报销额都下降

血压低于 140 毫米汞柱时卒中减少，进一步支持指南采用更低阈值

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Menos ACV con Presiones Arteriales Menor que 140 mm Hg Animan a Rebajar los Umbrales

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

High Baseline Fitness Level Tied to Improved Survival After MI

Un Estudio Sugiere que las UCC Pueden Evitarse en Muchos Pacientes SCASEST

Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

研究表明，很多 NSTE-ACS 患者可以跳过 CCU 这一步

Study Suggests CCU Can Be Skipped for Many NSTE-ACS Patients

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content